Financial Year |
September 30 2020 |
Monetary Funds |
116,691,090.05 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
148,501,117.08 |
Accounts Receivable |
388,639,341.43 |
Advances to Suppliers |
26,748,218.86 |
Other Receivables |
6,823,537.87 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
415,925,215.10 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
2,128,851.43 |
Total Current Assets |
1,105,457,371.82 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
41,533,760.09 |
Investment Properties |
30,166,206.56 |
Fixed Assetes |
272,039,326.22 |
Under-construction Projects |
15,789,111.65 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
39,130,214.75 |
R&D expenses |
14,894,577.39 |
Goodwill |
92,167,939.31 |
Long-Term Deferred and Prepaid Expenses |
14,750,602.74 |
Deferred Income Tax Assets |
9,929,956.15 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
530,401,694.86 |
Total Assets |
1,635,859,066.68 |
Short-Term Loans |
199,060,092.71 |
Trading Financial liabilities |
-- |
Notes Payable |
800,000.00 |
Accounts Payable |
244,507,588.23 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
16,171,187.46 |
Taxes Payable |
11,022,465.56 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
17,663,705.02 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
44,890,779.61 |
Other Current Liabilities |
-- |
Sub-Total of Current Liabilities |
557,200,475.41 |
Long-term Loans |
158,530,000.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
3,939,674.38 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
169,883,279.84 |
Total Liabilities |
727,083,755.25 |
Paid-In Capital(Or Share Stock) |
165,580,800.00 |
Capital Surplus |
219,856,506.83 |
Surplus Reserve |
21,725,884.05 |
LESS:Treasury Stock |
15,079,272.00 |
Undistributed Profits |
338,274,306.22 |
Minority Stockholder's Interest |
178,417,086.33 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
730,358,225.10 |
Owner's Equity(Stockholder's Equity) |
908,775,311.43 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,635,859,066.68 |